MH701
MH 701 EXAM | Questions and Answers | 100% Correct
(Latest Update )
1. Can cause neural tube defects like spina bifida: valproic acid
2. Can cause hepatic necrosis: valproic acid
3. Carbamazepine (Tegretol) FDA: anticonvulsant/mood
stabilizer
4. Carbamazepine (Tegretol) Off-label: bipolar depression, bipolar
maintenance, psychosis
5. Carbamazepine (Tegretol) 3 main clinical uses: seizures,
trigeminal neuralgia, mood stabilizer
6. Lamictal (lamotrigine) FDA: mood stabilizer/anticonvulsant
approved for bipolar I maintenance
1
Page
, MH701
7. Lamictal (lamotrigine) Off-label: bipolar depression, bipolar
mania (adjunct and second line), neuropathic pain, MDD
(second line)
8. Lamictal watch out for: Rash! Stevens-Johnson Syndrome
9. Li 1.5–2.0: mild to moderate toxicity – vomiting, abdominal
pain, dry mouth, ataxia, slurred speech, dizziness, lethargy or
excitement, muscle weakness
10. Li 2.0–2.5: moderate to severe toxicity – anorexia,
nausea/vomiting, blurred vision, fasciculations, clonic
movements, increased DTRs, choreoathetoid movements,
convulsions, delirium, syncope, EEG changes, stupor, coma,
circulatory failure (arrhythmia, low BP, conduction
abnormalities)
11. Li >2.5: severe toxicity – convulsions, oliguria, renal failure,
death
2
Page
MH 701 EXAM | Questions and Answers | 100% Correct
(Latest Update )
1. Can cause neural tube defects like spina bifida: valproic acid
2. Can cause hepatic necrosis: valproic acid
3. Carbamazepine (Tegretol) FDA: anticonvulsant/mood
stabilizer
4. Carbamazepine (Tegretol) Off-label: bipolar depression, bipolar
maintenance, psychosis
5. Carbamazepine (Tegretol) 3 main clinical uses: seizures,
trigeminal neuralgia, mood stabilizer
6. Lamictal (lamotrigine) FDA: mood stabilizer/anticonvulsant
approved for bipolar I maintenance
1
Page
, MH701
7. Lamictal (lamotrigine) Off-label: bipolar depression, bipolar
mania (adjunct and second line), neuropathic pain, MDD
(second line)
8. Lamictal watch out for: Rash! Stevens-Johnson Syndrome
9. Li 1.5–2.0: mild to moderate toxicity – vomiting, abdominal
pain, dry mouth, ataxia, slurred speech, dizziness, lethargy or
excitement, muscle weakness
10. Li 2.0–2.5: moderate to severe toxicity – anorexia,
nausea/vomiting, blurred vision, fasciculations, clonic
movements, increased DTRs, choreoathetoid movements,
convulsions, delirium, syncope, EEG changes, stupor, coma,
circulatory failure (arrhythmia, low BP, conduction
abnormalities)
11. Li >2.5: severe toxicity – convulsions, oliguria, renal failure,
death
2
Page
